Ergomed (ERGO)

 

Latest News

CEL-SCI Corporation issues restricted shares

RNS Number: 5035O Ergomed plc 21 August 2017 PRESS RELEASE FOR IMMEDIATE RELEASE CEL-SCI Corporation issues restricted shares to Ergomed for partial settlement of receivable London, UK - 21 August 2017: Ergomed plc (LSE: ERGO) ('Ergomed' or the 'Company'), a company dedicated to the provision of specialised services to the pharmaceutical indu...

Ergomed's partner to resume Phase 3 study of Multikine

Ergomed said it has noted that its co-development partner CEL-SCI has confirmed the US Food and Drug Administration ...

FDA removal of hold on Ph3 trial with Multikine

RNS Number: 9319N Ergomed plc 14 August 2017 PRESS RELEASE Ergomed notes announcement by co-development partner, CEL-SCI, of FDA removal of clinical hold on Phase 3 clinical trial with Multikine in head and neck cancer London, UK - 14 August 2017: Ergomed plc (LSE: ERGO) ('Ergomed' or 'the Company'), a specialised pharmaceutical services and dr...

Ergomed schedules interim results

Ergomed, a specialised pharmaceutical services and drug development company, will announce its results for the six mont...

All News

DateHeadlineSource
21-08-17CEL-SCI Corporation issues restricted sharesRNS
14-08-17Ergomed's partner to resume Phase 3 study of MultikineStockMarketWire
14-08-17FDA removal of hold on Ph3 trial with MultikineRNS
14-08-17Ergomed schedules interim results StockMarketWire
14-08-17Notice of ResultsRNS
24-07-17Ergomed completes study recruitment ahead of schedule StockMarketWire
24-07-17Recruitment complete early for Phase IIb studyRNS
04-07-17Investor MeetingRNS
21-06-17PeproStat study passes recruitment mid-pointRNS
19-06-17Ergomed resolutions passed at AGMStockMarketWire
16-06-17Result of AGMRNS
16-06-17Ergomed appoints CEOStockMarketWire
16-06-17Appointment of CEORNS
13-06-17Ergomed to present at the Shares Spotlight Evening in Manchester on 29 June 2017StockMarketWire
22-05-17Appointment of N+1 Singer as joint brokerRNS
12-05-17Annual Report and Notice of AGMRNS
08-05-17Ergomed updates in PharmInvent earn-outStockMarketWire
08-05-17Issue of Shares to Former PharmInvent ShareholdersRNS
02-05-17Broker Forecast - Stifel issues a broker note on Ergomed PlcStockMarketWire
02-05-17Broker Forecast - Numis issues a broker note on Ergomed PlcStockMarketWire
02-05-17Co-Development Partner NewsRNS
26-04-1711 shares where positive earnings shocks could trigger ralliesInteractive Investor
13-04-17Board and Management ChangesRNS
04-04-17Director Deals - Ergomed Plc (ERGO)StockMarketWire
04-04-17Director/PDMR ShareholdingRNS
03-04-17Ergomed partner announces successful dataStockMarketWire
03-04-17Partner Asarina Pharma announces successful dataRNS
28-03-17Ergomed revenues up 30%StockMarketWire
28-03-17Ergomed revenues up StockMarketWire
28-03-17Unaudited Preliminary Results for 2016RNS
21-03-17Notice of Preliminary ResultsRNS
20-03-17Ergomed initiates study of PeprostatStockMarketWire
20-03-17Initiates Phase II Study of Topical PeproStatRNS
20-02-17Ergomed notes partner's successful financing roundStockMarketWire
20-02-17Modus Therapeutics Raises SEK 32 MillionRNS
06-02-17Broker Forecast - Numis issues a broker note on Ergomed PlcStockMarketWire
06-02-17Broker Forecast - Stifel issues a broker note on Ergomed PlcStockMarketWire
06-02-17Positive Phase II top-line results of LorediplonRNS
03-02-17Broker Forecast - N+1 Singer issues a broker note on Ergomed PlcStockMarketWire
31-01-17Completion of ZoptrexT Phase 3 Clinical TrialRNS

RSS feeds

  • Editorial news feed for LSE:ERGO Editorial
  • Regulatory news feed for LSE:ERGO Regulatory